ÂÜÀòÂÒÂ×

Vladimir has 30+ years of industry experience in drug development, all phases, and recently over 10 years in oncology development. He was the Executive Director at Amgen Global Biosimilars Development. His deep knowledge of biosimilar oncology regulatory approval and CMC challenges will be a great addition to the NGM’s overall expertise. He has successfully developed a number of biosimilars for Amgen. He has managed a fairly large team at Amgen, including clinical development, pharmacovigilance and medical affairs with a mindset and strength in establishing a performance-based culture. He is fluent in English, German, and understands Japanese. Before Amgen, he worked at Boehringer Ingelheim and Schering AG.